Pharma 5.0

Strong data foundations determine success in AI/ML

Published: 5-Feb-2026

AI and machine learning are increasingly embedded across the chemical R&D lifecycle, from discovery to QA/QC, with their greatest value emerging when high-quality, standardised data enables adaptive modelling that supports scientific judgement

You need to be a subscriber to read this article.
Click here to find out more.

Artificial intelligence (AI) and machine learning (ML) are no longer futuristic technologies in chemical R&D.

While their first use was for productivity gains in business units, scientists are making inroads in AI/ML adoption.

Organisations are using AI/ML to accelerate experimentation and analysis across the design-make-test-analyse (DMTA) cycle.

The greatest value is emerging as AI is embedded into digital-physical workflows, where continuously captured and contextualised data enables adaptive modelling that enhances — rather than replaces — scientific judgement.

Emily Letton speaks to ACD/Labs’ Dr Sanji Bhal for further insight.

From experiments to “experimental stories”

The power of AI and machine learning (AI/ML) rests on data quality, accessibility and continuity.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.

You may also like